CDC And FDA Recommend US Pause Use Of Johnson & Johnson Vaccine Over Blood Clot Concerns

The US Centers for Disease Control and Prevention and the US Food and Drug Administration have recommended the United States pause the use of Johnson & Johnson’s Covid-19 vaccine over blood clot concerns.

Six reported cases found a “rare and severe” type of blood clot, according to a press release. The six cases were among the 6.8 million doses of the Johnson & Johnson vaccine administered in the United States. All six cases were women between the ages of 18 and 48.

“CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance,” the statement said. “FDA will review that analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution. This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot.”

This is a breaking news story and will be updated.

Related Posts